BRIGHT MINDS BIOSCIENCES INC (DRUG) Stock Analyst Ratings
NASDAQ:DRUG - Nasdaq - CA10919W4056 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 86% to DRUG. The Buy consensus is the weighted average rating of the current analysts ratings.
DRUG was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about DRUG.
In the previous month the buy percentage consensus was at a similar level.
DRUG was analyzed by 7 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-23 | Piper Sandler | Initiate | Overweight |
| 2025-01-10 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-01-10 | HC Wainwright & Co. | Initiate | Buy |
| 2024-11-25 | Baird | Initiate | Outperform |